N-GLYcanyzer: An Automated Process Analytical Platform for Continuous Manufacturing of Biologics

Explore an automated analytical toolkit for monitoring protein N-glycosylation in biologics manufacturing through this 31-minute panel presentation. Learn about the N-GLYcanyzer, developed by the Chundawat group at Rutgers University, which enables near real-time monitoring and control of critical quality attributes during continuous biomanufacturing processes. Discover key features of this innovative platform and see examples of its application in monitoring a continuous upstream mammalian cell culture process for producing a Trastuzumab biosimilar. Gain insights into how this technology supports the biopharmaceutical industry's transition towards continuous manufacturing, ensuring the production of high-quality biologics with desired safety and efficacy profiles.